NCT02667041View on ClinicalTrials.gov

NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Depressive Disorder, Major
Interventions
DEVICE

NeuroQore rTMS Device

Trial Locations (1)

K1Z7K4

Royal Ottawa Mental Health Centre, Ottawa

Sponsors

Collaborators (1)

NeuroQore Inc.
All Listed Sponsors
collaborator

NeuroQore Inc.

INDUSTRY

lead

University of Ottawa

OTHER

NCT02667041 - NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial | Biotech Hunter | Biotech Hunter